Tiny particles made from the membranes of human immune cells could offer a promising new way to fight fungal infections that are becoming harder to treat. The antifungal nanoparticles target Candida albicans, a fungus responsible for oral and vaginal yeast infections and bloodstream infections.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
